Catridecacog
- Generic Name
- Catridecacog
- Brand Names
- Novothirteen, Tretten, NovoThirteen
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 606138-08-3
- Unique Ingredient Identifier
- NU23Q531G1
- Background
Coagulation Factor XIII A-Subunit (Recombinant), also known as catridecacog, is a recombinant form of the Factor XIII-A2 homodimer composed of two factor XIII (FXIII) A-subunits . For people with congenital deficiency or mutation of Factor XIII, a rare bleeding disorder, exogenous replacement of this key coagulation factor is essential for management and pre...
- Indication
For routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.
- Associated Conditions
- Bleeding
- Associated Therapies
- -
Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery
- Conditions
- Interventions
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 479
- Registration Number
- NCT00914589
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Southampton, United Kingdom
Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency
- Conditions
- Interventions
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 41
- Registration Number
- NCT00713648
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Newcastle upon Tyne, United Kingdom
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
- Conditions
- Interventions
- First Posted Date
- 2003-03-20
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 11
- Registration Number
- NCT00056589
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.